Trials / Unknown
UnknownNCT02104297
Effect of Deksmedetomidine and Remifentanil in Extubation Agitation
The Effect of Deksmedetomidin and Remifentanil Infusion on Extubation Agitation and Recovery Conditions on Nasal Septoplasty Operation
- Status
- Unknown
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 90 (estimated)
- Sponsor
- Diskapi Yildirim Beyazit Education and Research Hospital · Other Government
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Accepted
Summary
To compare the effect of two different agents deksmedetomidine, remifentanil and placebo, agitation and recovery condition, on nasal septum operation.
Detailed description
Nasal septum operation cause agitation because of nasal package. This research aims determine which agent , deksmedetomidine remifentanil or placebo, is more beneficial to the patient.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | deksmedetomidine | deksmedetomidine infused during operation 0.2 mcg/kg/hour |
| DRUG | Remifentanil | Remifentanil infused during operation 0.2 mcg/kg/min |
| DRUG | Saline | During operation saline infused equal volüme of deksmedetomidine and remifentanil |
Timeline
- Start date
- 2014-04-01
- Primary completion
- 2014-06-01
- Completion
- 2014-06-01
- First posted
- 2014-04-04
- Last updated
- 2014-04-04
Locations
1 site across 1 country: Turkey (Türkiye)
Source: ClinicalTrials.gov record NCT02104297. Inclusion in this directory is not an endorsement.